Procter & Gamble Health Profit & Loss Annual

Trade
BSE: 500126 | NSE: PGHL | ISIN: INE199A01012 | Sector: Biotechnology & Drugs
5,299.30 -30.55 (-0.57%)Updated : 09 Oct 2024
Fiscal Period2024202320222021
Period End DateJun 24Jun 23Jun 22Jun 21
Revenue 283.881,229.621,114.411,008.73
Total Revenue 283.881,229.621,114.411,008.73
Costof Revenue Total 79.17434.30410.87344.92
Gross Profit 204.71795.32703.54663.81
Selling/ General/ Admin Expenses Total 48.63436.37412.90405.06
Depreciation/ Amortization 7.1627.7626.7329.69
Unusual Expense( Income) 20.1911.935.910.48
Other Operating Expenses Total 107.8316.639.967.90
Total Operating Expense 262.98933.04873.27792.33
Operating Income 20.90296.58241.14216.40
Interest Inc( Exp) Net- Non- Op Total -2.00139.0094.60142.60
Other Net 2.133.013.313.04
Net Income Before Taxes 22.83314.20253.37233.28
Provisionfor Income Taxes 6.0584.7360.8556.48
Net Income After Taxes 16.78229.47192.52176.80
Net Income Before Extra Items 16.78229.47192.52176.80
Net Income 16.78229.47192.52176.80
Income Availableto Com Excl Extra Ord 16.78229.47192.52176.80
Income Availableto Com Incl Extra Ord 16.78229.47192.52176.80
Diluted Net Income 16.78229.47192.52176.80
Diluted Weighted Average Shares 1.661.661.661.66
Diluted EPS Excluding Extra Ord Items 10.11138.24115.98106.51
DPS- Common Stock Primary Issue 110.0095.0052.5040.00
Diluted Normalized EPS 19.05143.18118.93106.92
Research Development -57.1065.5039.30
Interest Exp( Inc) Net- Operating Total -3.403.503.50
Gain( Loss)on Saleof Assets -7.10-5.40-4.20
*All figures in crores except per share values
Recommended For You
Trending Stocks
939.15+19.30(2.10%)
1,658.70+30.25(1.86%)
491.80-16.10 (-3.17%)
2,516.70-64.80 (-2.51%)
HomeMarketsPremiumInstant LoanMint Shorts